Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Shashi

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Medical Genetics|October 3, 1999
Genetic heterogeneity of gingival fibromatosis on chromosome 2pV Shashi, D Pallos, M J Pettenati, et al.
Clinical Genetics|February 14, 2015
Practical considerations in the clinical application of whole-exome sequencingV Shashi, A McConkie-Rosell, K Schoch, et al.
Journal of Intellectual Disability Research : JIDR|April 15, 2015
Social cognitive training in adolescents with chromosome 22q11.2 deletion syndrome: feasibility and preliminary effects of the interventionV Shashi, W Harrell, S Eack, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 1996
Ovarian granulosa cell tumors with bizarre nuclei: an immunohistochemical analysis with fluorescence in situ hybridization documenting trisomy 12 in the bizarre component [corrected]M J Gaffey, H F Frierson, J C Iezzoni, et al.
Translational Psychiatry|July 27, 2012
Dysregulation of DGCR6 and DGCR6L: psychopathological outcomes in chromosome 22q11.2 deletion syndromeR Das Chakraborty, D Chakraborty, A J Bernal, et al.
Clinical Genetics|September 27, 2014
The RBMX gene as a candidate for the Shashi X-linked intellectual disability syndromeV Shashi, P Xie, K Schoch, et al.
Translational Psychiatry|February 22, 2017
No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patientsM Guipponi, F Santoni, M Schneider, et al.
Molecular Syndromology|May 9, 2013
Evaluation of Clinical Manifestations in Patients with Severe Lymphedema with and without CCBE1 MutationsM Alders, A Mendola, L Adès, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|December 28, 2017
Persistence, dissipation and consumer risk assessment of a combination formulation of flubendiamide and deltamethrin on cucumberK K Sharma, V Shashi Bhushan, Cherukuri Sreenivasa Rao, et al.
Molecular Psychiatry|October 11, 2017
Dose-dependent expression of claudin-5 is a modifying factor in schizophreniaC Greene, J Kealy, M M Humphries, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Medical Genetics|October 3, 1999
Genetic heterogeneity of gingival fibromatosis on chromosome 2pV Shashi, D Pallos, M J Pettenati, et al.
Clinical Genetics|February 14, 2015
Practical considerations in the clinical application of whole-exome sequencingV Shashi, A McConkie-Rosell, K Schoch, et al.
Journal of Intellectual Disability Research : JIDR|April 15, 2015
Social cognitive training in adolescents with chromosome 22q11.2 deletion syndrome: feasibility and preliminary effects of the interventionV Shashi, W Harrell, S Eack, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 1996
Ovarian granulosa cell tumors with bizarre nuclei: an immunohistochemical analysis with fluorescence in situ hybridization documenting trisomy 12 in the bizarre component [corrected]M J Gaffey, H F Frierson, J C Iezzoni, et al.
Translational Psychiatry|July 27, 2012
Dysregulation of DGCR6 and DGCR6L: psychopathological outcomes in chromosome 22q11.2 deletion syndromeR Das Chakraborty, D Chakraborty, A J Bernal, et al.
Clinical Genetics|September 27, 2014
The RBMX gene as a candidate for the Shashi X-linked intellectual disability syndromeV Shashi, P Xie, K Schoch, et al.
Translational Psychiatry|February 22, 2017
No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patientsM Guipponi, F Santoni, M Schneider, et al.
Molecular Syndromology|May 9, 2013
Evaluation of Clinical Manifestations in Patients with Severe Lymphedema with and without CCBE1 MutationsM Alders, A Mendola, L Adès, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|December 28, 2017
Persistence, dissipation and consumer risk assessment of a combination formulation of flubendiamide and deltamethrin on cucumberK K Sharma, V Shashi Bhushan, Cherukuri Sreenivasa Rao, et al.
Molecular Psychiatry|October 11, 2017
Dose-dependent expression of claudin-5 is a modifying factor in schizophreniaC Greene, J Kealy, M M Humphries, et al.
Pageof 3